$CLX·4

CLOROX CO /DE/ · Feb 22, 4:55 PM ET

CLOROX CO /DE/ 4

4 · CLOROX CO /DE/ · Filed Feb 22, 2017

Insider Transaction Report

Form 4
Period: 2017-02-17
JOHNSON THOMAS D
Vice President-Controller
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-02-173,5920 total
    Exercise: $72.11From: 2013-09-11Exp: 2022-09-11Common Stock (3,592 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-02-173,0103,010 total
    Exercise: $84.45From: 2014-09-17Exp: 2023-09-17Common Stock (3,010 underlying)
  • Exercise/Conversion

    Common Stock

    2017-02-17$72.11/sh+3,592$259,01917,115 total
  • Sale

    Common Stock

    2017-02-17$133.39/sh10,626$1,417,42712,754 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-02-173,2556,510 total
    Exercise: $89.82From: 2015-09-17Exp: 2024-09-17Common Stock (3,255 underlying)
  • Exercise/Conversion

    Common Stock

    2017-02-17$89.92/sh+3,255$292,69020,370 total
  • Exercise/Conversion

    Common Stock

    2017-02-17$84.45/sh+3,010$254,19523,380 total
Holdings
  • Common Stock

    (indirect: By Trust)
    400
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $133.15 to $133.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    doc4.xmlPrimary